Bedfont® Scientific Limited, an innovative MedTech company specializing in the design and manufacture of medical breath analyzers, is thrilled to have been shortlisted in the Export Performance category of the Science and Engineering Health Technologies Alliance (SEHTA) Healthcare Business Awards 2026.
The SEHTA Healthcare Business Awards are one of the Southeast’s leading healthcare innovation awards, celebrating excellence in healthcare, particularly life sciences and medical technology. Bedfont® is a world leader in breath analysis and has experienced significant growth over the past decade, with a strong focus on international sales, with over 59% of export sales contributing to annual sales.
Being shortlisted for the Export Achievement Award recognizes the hard work of our team and our mission to improve healthcare outcomes around the world. Our international growth is a key part of our strategy and we are proud to represent British innovation on the world stage. ”
Jason Smith, Bedfont® CEO
Bedfont® has a global network of over 100 distributors and prioritizes long-term partnerships built on trust and cooperation. The company understands that entering new markets is a gradual process that requires continued investment in relationships and a regionally tailored approach. Bedfont® ensures its solutions are relevant and effective around the world by adapting its services, support and go-to-market strategies to local needs.
The awards ceremony, scheduled to be held at Imperial College London’s Scale Space on Tuesday 26 May, will bring together businesses from across the South East to celebrate innovation in healthcare.
